Monitor progress toward FOAK plant construction and commissioning, as well as future announcements regarding definitive offtake agreements or additional partners. The initial parcel sale will be a key milestone for commercial validation.
Price Chart
Executive Summary
Aduro Clean Technologies announced a non-binding Letter of Intent with an unnamed international commodities trader to evaluate its Hydrochemolytic™ oil for future offtake, including a binding commitment to purchase the initial production parcel from Aduro’s first industrial plant in the Netherlands. The arrangement supports technical validation and early commercial pathway development but does not include binding long-term volume or pricing terms.
Key Facts
- Aduro signed a non-binding LOI with a global commodities trader for evaluation and potential offtake of Hydrochemolytic™ oil.
- The trader committed to purchase the initial production parcel from Aduro’s FOAK Industrial Plant in Geleen, Netherlands.
- Phase 1 involves pilot-scale testing and product characterization; Phase 2 includes commercial validation upon plant commissioning.
- The LOI is non-exclusive and preserves Aduro’s ability to secure additional offtake partners.
- Except for the initial parcel purchase, all terms are non-binding and subject to definitive agreements.
Financial Impact
Initial production parcel value not disclosed; no revenue impact until FOAK plant operates and sale occurs.
Risk Factors
- FOAK plant construction or commissioning delays could push back revenue realization.
- Pilot-scale results may not replicate at industrial scale, risking product qualification failure.
- Definitive agreements may not be reached, or terms could be less favorable than expected.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3254533 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 6-K | $10.13 | awaiting T+60 | — | $9.62 (−5.03%) |
Oct 15, 2026 11d ago | 6-K | $9.95 | awaiting T+60 | — | $9.62 (−3.27%) |
Sep 28, 2026 28d ago | SC 13D/A | $12.25 | awaiting T+60 | — | $9.62 (−21.47%) |
Sep 25, 2026 4w ago | SC 13D/A | $12.31 | awaiting T+60 | — | $9.62 (−21.85%) |
Sep 1, 2026 8w ago | Press Release | $13.34 | awaiting T+60 | — | $9.62 (−27.89%) |
Aug 21, 2026 9w ago | Institutional Cluster | $16.04 | awaiting T+60 | — | $9.62 (−40.02%) |
Jun 25, 2026 17w ago | 6-K | $15.21 $12.61 | ▼ −17.09% | ▼ −23.20% | $9.62 (−36.75%) |
Jun 17, 2026 18w ago | Press Release | $14.72 $12.90 | ▼ −12.36% | ▼ −15.51% | $9.62 (−34.65%) |
Jun 12, 2026 19w ago | 6-K | $14.81 $13.26 | ▲ +10.47% | ▲ +11.47% | $9.62 (+35.04%) |
Jun 10, 2026 19w ago | 6-K | $15.10 $13.58 | ▼ −10.07% | ▼ −14.46% | $9.62 (−36.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers